Allergy Immunotherapy Market Size, Share, Growth Report 2030

Allergy Immunotherapy Market

Allergy Immunotherapy Market by Treatment Type (SCIT and SLIT), by Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Stores, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 30-Jul-2019 Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-4511 Status : Published

Global allergy immunotherapy market expected to generate around USD 3.76 billion by 2025, at a CAGR of around 10.5% between 2019 and 2025. Allergy immunotherapy is a type of immunotherapy where the person suffering from certain any kind of allergy is exposed to a particular type of allergen till the time his/her immune system modifies.

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global allergy immunotherapy market, 2016-2025 (USD Billion)
    • 2.2. Global allergy immunotherapy market: Snapshot
  •  
  • Chapter 3. Allergy Immunotherapy Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global allergy immunotherapy market drivers: Impact analysis
      • 3.2.2. Rising prevalence of allergic diseases
      • 3.2.3. Increasing awareness about allergy treatment
      • 3.2.4. High clinical R&D budget by governments and non-profit organizations
    • 3.3. Market Restraints
      • 3.3.1. Global allergy immunotherapy market restraints: Impact analysis
      • 3.3.2. The dearth of Trained Professionals
      • 3.3.3. High Cost of Procedure
    • 3.4. Opportunities
      • 3.4.1. Promising product pipeline
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by treatment type
      • 3.6.2. Market attractiveness analysis, by allergy type
      • 3.6.3. Market attractiveness analysis, by distribution channel
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Allergy Immunotherapy Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global allergy immunotherapy market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Allergy Immunotherapy Market - Treatment Type Analysis
    • 5.1. Global allergy immunotherapy market: Treatment Type overview
      • 5.1.1. Global allergy immunotherapy market revenue share, by treatment type, 2018 and 2025
    • 5.2. SCIT
      • 5.2.1. Global allergy immunotherapy market for SCIT, 2016-2025 (USD Billion)
    • 5.3. SLIT
      • 5.3.1. Global allergy immunotherapy market for SLIT, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Allergy Immunotherapy Market - Allergy Type Analysis
    • 6.1. Global allergy immunotherapy market: Allergy Type overview
      • 6.1.1. Global allergy immunotherapy market revenue share, by allergy type, 2018 and 2025
    • 6.2. Allergic Rhinitis
      • 6.2.1. Global allergy immunotherapy market for allergic rhinitis, 2016-2025 (USD Billion)
    • 6.3. Asthma
      • 6.3.1. Global allergy immunotherapy market for asthma, 2016-2025 (USD Billion)
    • 6.4. Food Allergy
      • 6.4.1. Global allergy immunotherapy market for food allergy, 2016-2025 (USD Billion)
    • 6.5. Venom Allergy
      • 6.5.1. Global allergy immunotherapy market for venom allergy, 2016-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global allergy immunotherapy market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Allergy Immunotherapy Market - Distribution Channel Analysis
  • 7.1. Global allergy immunotherapy market: Distribution Channel overview
    • 7.1.1. Global allergy immunotherapy market revenue share, by distribution channel, 2018 and 2025
  • 7.2. Retail Pharmacy and Drug Stores
    • 7.2.1. Global allergy immunotherapy market for retail pharmacy and drug stores, 2016-2025 (USD Billion)
  • 7.3. Hospital Pharmacy
    • 7.3.1. Global allergy immunotherapy market for hospital pharmacy, 2016-2025 (USD Billion)
  • 7.4. Online Pharmacy
    • 7.4.1. Global allergy immunotherapy market for online pharmacy, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Allergy Immunotherapy Market - Regional Analysis
    • 8.1. Global allergy immunotherapy market: Regional overview
      • 8.1.1. Global allergy immunotherapy market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.2.2. North America allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.2.3. North America allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.2.4. North America allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.2.5.2. The U.S. allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.2.5.3. The U.S. allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.2.6. Canada
        • 8.2.6.1. Canada allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.2.6.2. Canada allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.2.6.3. Canada allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.3.2. Europe allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.3.3. Europe allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.3.4. Europe allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.5.2. UK allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.5.3. UK allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.6. Germany
        • 8.3.6.1. Germany allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.6.2. Germany allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.6.3. Germany allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.7.2. France allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.7.3. France allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.3.8.2. Rest of Europe allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.3.8.3. Rest of Europe allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.4.4. Asia Pacific allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.5.2. China allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.5.3. China allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.6.2. Japan allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.6.3. Japan allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.7.2. India allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.7.3. India allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.5.2. Latin America allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.5.3. Latin America allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.5.4. Latin America allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.5.5.2. Brazil allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.5.5.3. Brazil allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
        • 8.5.6.2. Rest of Latin America allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
        • 8.5.6.3. Rest of Latin America allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa allergy immunotherapy market, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa allergy immunotherapy market revenue, by treatment type, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa allergy immunotherapy market revenue, by allergy type, 2016-2025 (USD Billion)
      • 8.6.4. The Middle East and Africa allergy immunotherapy market revenue, by distribution channel, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Stallergenes Greer
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Aimmune Therapeutics
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. ALK-Abello
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Allergy Therapeutics
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Merck
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. HAL Allergy
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. DBV Technologies
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Circassia
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Biomay
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Anergis
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global allergy immunotherapy market revenue, 2016–2025 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Allergy Immunotherapy market attractiveness analysis, by treatment type
6. Allergy Immunotherapy market attractiveness analysis, by allergy type
7. Allergy Immunotherapy market attractiveness analysis, by distribution channel
8. Allergy Immunotherapy market: market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global allergy immunotherapy market share by treatment type, 2018 and 2025
11. Global allergy immunotherapy market for SCIT, 2016–2025 (USD Billion)
12. Global allergy immunotherapy market for SLIT, 2016–2025 (USD Billion)
13. Global allergy immunotherapy market share by allergy type, 2018 and 2025
14. Global allergy immunotherapy market for allergic rhinitis, 2016–2025 (USD Billion)
15. Global allergy immunotherapy market for asthma, 2016–2025 (USD Billion)
16. Global allergy immunotherapy market for food allergy, 2016–2025 (USD Billion)
17. Global allergy immunotherapy market for venom allergy, 2016–2025 (USD Billion)
18. Global allergy immunotherapy market for others, 2016–2025 (USD Billion)
19. Global allergy immunotherapy market share by distribution channel, 2018 and 2025
20. Global allergy immunotherapy market for retail pharmacy and drug stores, 2016–2025 (USD Billion)
21. Global allergy immunotherapy market for hospital pharmacy, 2016–2025 (USD Billion)
22. Global allergy immunotherapy market for online pharmacy, 2016–2025 (USD Billion)
23. North America allergy immunotherapy market, 2016–2025 (USD Billion)
24. Europe allergy immunotherapy market, 2016–2025 (USD Billion)
25. Asia Pacific allergy immunotherapy market, 2016–2025 (USD Billion)
26. Latin America allergy immunotherapy market,2016–2025 (USD Billion)
27. The Middle East and Africa allergy immunotherapy market, 2016–2025 (USD Billion)


Table Of Tables

List of Tables

1. Global allergy immunotherapy market: Market Snapshot
2. Drivers of the global allergy immunotherapy market: Impact analysis 
3. Restraints of the global allergy immunotherapy market: Impact analysis  
4. North America allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
5. North America allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
6. North America allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
7. The U.S. allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
8. The U.S. allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
9. The U.S. allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
10. Canada allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
11. Canada allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
12. Canada allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
13. Europe allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
14. Europe allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
15. Europe allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
16. UK allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
17. UK allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
18. UK allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
19. Germany allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
20. Germany allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
21. Germany allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
22. France allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
23. France allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
24. France allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
25. Rest of Europe allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
26. Rest of Europe allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
27. Rest of Europe allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
28. Asia Pacific allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
29. Asia Pacific allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
30. Asia Pacific allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
31. China allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
32. China allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
33. China allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
34. Japan allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
35. Japan allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
36. Japan allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
37. India allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
38. India allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
39. India allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
40. Rest of Asia Pacific allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
41. Rest of Asia Pacific allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
42. Rest of Asia Pacific allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
43. Latin America allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
44. Latin America allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
45. Latin America allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
46. Brazil allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
47. Brazil allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
48. Brazil allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
49. Rest of Latin America allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
50. Rest of Latin America allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
51. Rest of Latin America allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)
52. The Middle East and Africa allergy immunotherapy market revenue, by treatment type, 2016–2025 (USD Billion)
53. The Middle East and Africa allergy immunotherapy market revenue, by allergy type, 2016–2025 (USD Billion)
54. The Middle East and Africa allergy immunotherapy market revenue, by distribution channel, 2016–2025 (USD Billion)

Methodology

Free Analysis

Choose License Type

  • zion payment modes

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed